Search results for "Different"

showing 10 items of 8549 documents

"Table 8" of "Measurement of inclusive jet and dijet cross sections in proton-proton collisions at 7 TeV centre-of-mass energy with the ATLAS detecto…

2010

Inclusive jet double-differential cross sections in the |rapidity| range 0.8 to 1.2, using a jet resolution R value of 0.6. The three (sys) errors are respectively, the Absolute JES, the Unfolding and the Luminosity uncertainties.

26119402611940Astrophysics::High Energy Astrophysical PhenomenaRapidity Dependence7000.0Astrophysics::Cosmology and Extragalactic AstrophysicsJet ProductionP P --> JET XInclusiveProton-Proton ScatteringHigh Energy Physics::ExperimentD2SIG/DPT/DYRAPTransverse Momentum DependenceDouble Differential Cross SectionAstrophysics::Galaxy Astrophysics
researchProduct

"Table 29" of "K$^{*}(892)^{0}$ and $\phi(1020)$ meson production at high transverse momentum in pp and Pb-Pb collisions at $\sqrt{s_\mathrm{NN}}$ = …

2017

p/$\phi$ ratio as a function of $p_{\rm T}$ for inelastic (INEL) pp collisions at $\sqrt{s}=2.76~{\rm TeV}$.

2760.0pT differential particle ratioHigh Energy Physics::ExperimentP P --> Phi XNuclear Experiment
researchProduct

"Table 19" of "K$^{*}(892)^{0}$ and $\phi(1020)$ meson production at high transverse momentum in pp and Pb-Pb collisions at $\sqrt{s_\mathrm{NN}}$ = …

2017

$\phi$/K ratio as a function of $p_{\rm T}$ for inelastic (INEL) pp collisions at $\sqrt{s}=2.76~{\rm TeV}$.

2760.0pT differential particle ratioHigh Energy Physics::ExperimentP P --> Phi XNuclear Experiment
researchProduct

"Table 23" of "K$^{*}(892)^{0}$ and $\phi(1020)$ meson production at high transverse momentum in pp and Pb-Pb collisions at $\sqrt{s_\mathrm{NN}}$ = …

2017

$\phi$/$\pi$ ratio as a function of $p_{\rm T}$ for inelastic (INEL) pp collisions at $\sqrt{s}=2.76~{\rm TeV}$.

2760.0pT differential particle ratioHigh Energy Physics::ExperimentP P --> Phi XNuclear Experiment
researchProduct

"Table 18" of "K$^{*}(892)^{0}$ and $\phi(1020)$ meson production at high transverse momentum in pp and Pb-Pb collisions at $\sqrt{s_\mathrm{NN}}$ = …

2017

$\phi$/K ratio as a function of $p_{\rm T}$ for 0-5$\%$ centrality in Pb-Pb collisions at $\sqrt{s_{\rm NN}}=2.76~{\rm TeV}$.

2760.0pT differential particle ratioPB PB --> Phi X
researchProduct

"Table 27" of "K$^{*}(892)^{0}$ and $\phi(1020)$ meson production at high transverse momentum in pp and Pb-Pb collisions at $\sqrt{s_\mathrm{NN}}$ = …

2017

p/$\phi$ ratio as a function of $p_{\rm T}$ for 0-5$\%$ centrality in Pb-Pb collisions at $\sqrt{s_{\rm NN}}=2.76~{\rm TeV}$.

2760.0pT differential particle ratioPB PB --> Phi X
researchProduct

"Table 22" of "K$^{*}(892)^{0}$ and $\phi(1020)$ meson production at high transverse momentum in pp and Pb-Pb collisions at $\sqrt{s_\mathrm{NN}}$ = …

2017

$\phi$/$\pi$ ratio as a function of $p_{\rm T}$ for 0-5$\%$ centrality in Pb-Pb collisions at $\sqrt{s_{\rm NN}}=2.76~{\rm TeV}$

2760.0pT differential particle ratioPB PB --> Phi X
researchProduct

"Table 28" of "K$^{*}(892)^{0}$ and $\phi(1020)$ meson production at high transverse momentum in pp and Pb-Pb collisions at $\sqrt{s_\mathrm{NN}}$ = …

2017

p/$\phi$ ratio as a function of $p_{\rm T}$ for 60-80$\%$ centrality in Pb-Pb collisions at $\sqrt{s_{\rm NN}}=2.76~{\rm TeV}$.

2760.0pT differential particle ratioPB PB --> Phi X
researchProduct

Spray dried hyaluronic acid microparticles for adhesion controlled aggregation and potential stimulation of stem cells

2017

Spray-dried microparticles of a derivative of hyaluronic acid (HA) have been engineered to obtain a controlled aggregation with Human Mesenchymal Stem Cells (hMSCs) into 3D constructs. We demonstrated the utility of chemical functionalization of a native constituent of the extracellular matrix to improve processing performances and to control on stem cell adhesion and differentiation. Native hyaluronic acid (HA), cell adhesive peptides (RGD), transforming growth factor β3, dexamethasone are biological agents potentially suitable for chondrogenic stimulation of hMSCS. However unmodified HA suffers of drawbacks in terms of stability and versatility of processing. Functionalization strategies…

3003Hyaluronic acid0206 medical engineeringPharmaceutical Science02 engineering and technologyDexamethasoneExtracellular matrixchemistry.chemical_compoundTissue engineeringTransforming Growth Factor betaHyaluronic acidCell AdhesionHumansCell adhesionCells CulturedBottom-up approachStem cellMesenchymal Stromal CellTissue EngineeringChemistryMesenchymal stem cellMesenchymal Stem CellsCell DifferentiationAdhesion021001 nanoscience & nanotechnology020601 biomedical engineeringExtracellular MatrixBiochemistryMicroparticleSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoSurface modificationChondrogenesiStem cell0210 nano-technologyChondrogenesisHuman
researchProduct

Solid microcrystalline dispersion films as a new strategy to improve the dissolution rate of poorly water soluble drugs: A case study using olanzapine

2016

In this study, we evaluate the dissolution rate enhancement of solid microcrystalline dispersion (SMD) films of olanzapine (OLZ) formulated with four water-soluble polymers namely poly(N-vinylpyrrolidone) (PVP), poloxamer 188 (P188), poloxamer 407 (P407) and Soluplus(®) (SLP). Prepared formulations were characterised to determine particle size, morphology, hydrogen bonding interactions, thermal characteristics as well as in vitro dissolution studies conducted under sink conditions (pH 6.8). Particle size of OLZ in all formulations ranged between 42 and 58μm. Attenuated Total Reflectance Fourier Transform Infrared spectroscopy (ATR-FTIR), Differential Scanning Calorimetry (DSC) and Hot-Stage…

3003PVPDrug CompoundingSolid microcrystalline dispersionPharmaceutical SciencePoloxamer02 engineering and technologyPolyethylene Glycol030226 pharmacology & pharmacyPolyethylene GlycolsBenzodiazepines03 medical and health sciences0302 clinical medicineDifferential scanning calorimetrymedicineParticle SizePyrrolidinoneSolubilityFourier transform infrared spectroscopyPolymerPolyvinylDissolutionPharmaceutical filmBenzodiazepineChromatographyCrystallineChemistryHydrogen BondingPoloxamer021001 nanoscience & nanotechnologyPyrrolidinonesDrug LiberationMicrocrystallineSolubilityChemical engineeringOlanzapinePoloxamer 407PolyvinylsParticle sizeCrystallization0210 nano-technologymedicine.drugInternational Journal of Pharmaceutics
researchProduct